BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection
出版年份 2015 全文链接
标题
BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 112, Issue 12, Pages 1921-1928
出版商
Springer Nature
发表日期
2015-05-06
DOI
10.1038/bjc.2015.142
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinicopathologic characteristics and gene expression analyses of non-KRAS 12/13, RAS-mutated metastatic colorectal cancer
- (2014) V. K. Morris et al. ANNALS OF ONCOLOGY
- Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H)
- (2014) J. Goldstein et al. ANNALS OF ONCOLOGY
- BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer
- (2014) Rona Yaeger et al. CANCER
- Role ofNRASmutations as prognostic and predictive markers in metastatic colorectal cancer
- (2014) Marta Schirripa et al. INTERNATIONAL JOURNAL OF CANCER
- RAS Mutation Status Predicts Survival and Patterns of Recurrence in Patients Undergoing Hepatectomy for Colorectal Liver Metastases
- (2013) Jean-Nicolas Vauthey et al. ANNALS OF SURGERY
- From multidisciplinary to personalized treatment of colorectal liver metastases: 4 reasons to consider RAS
- (2013) Jean-Nicolas Vauthey et al. CANCER
- Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases
- (2013) Georgios Karagkounis et al. CANCER
- Massively Parallel Tumor Multigene Sequencing to Evaluate Response to Panitumumab in a Randomized Phase III Study of Metastatic Colorectal Cancer
- (2013) M. Peeters et al. CLINICAL CANCER RESEARCH
- Treatment of Metastatic Colon Cancer: “The Times They Are A-Changing”
- (2013) Nancy E. Kemeny JOURNAL OF CLINICAL ONCOLOGY
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
- (2013) Jean-Yves Douillard et al. NEW ENGLAND JOURNAL OF MEDICINE
- ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
- (2012) H. J. Schmoll et al. ANNALS OF ONCOLOGY
- Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
- (2012) Mi-Jung Kim et al. BMC CANCER
- KRASstatus and outcome of liver resection after neoadjuvant chemotherapy including bevacizumab
- (2012) S. Stremitzer et al. BRITISH JOURNAL OF SURGERY
- Poor prognosis ofKRASorBRAFmutant colorectal liver metastasis without microsatellite instability
- (2012) Yuzo Umeda et al. Journal of Hepato-Biliary-Pancreatic Sciences
- BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy
- (2012) Hao-Wei Teng et al. JOURNAL OF SURGICAL ONCOLOGY
- BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer
- (2011) T Yokota et al. BRITISH JOURNAL OF CANCER
- Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer
- (2011) Ben Tran et al. CANCER
- KRAS Mutation Is Associated with Lung Metastasis in Patients with Curatively Resected Colorectal Cancer
- (2011) J. Tie et al. CLINICAL CANCER RESEARCH
- Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
- (2011) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients’ outcome
- (2010) Z Saridaki et al. BRITISH JOURNAL OF CANCER
- Surgery for colorectal liver metastases
- (2010) J N Primrose BRITISH JOURNAL OF CANCER
- Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis
- (2010) Michihiro Hayashi et al. BMC Surgery
- Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer
- (2009) Myrddin Rees et al. ANNALS OF SURGERY
- Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer
- (2009) G. P. Schmidt et al. EUROPEAN RADIOLOGY
- KRASandBRAFMutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial
- (2009) Susan D. Richman et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
- (2009) Scott Kopetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Natural History of Patients with Subcentimeter Pulmonary Nodules Undergoing Hepatic Resection for Metastatic Colorectal Cancer
- (2009) Shishir K. Maithel et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- KRAS Mutations in Primary Colorectal Cancer Tumors and Related Metastases: A Potential Role in Prediction of Lung Metastasis
- (2009) Paloma Cejas et al. PLoS One
- Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
- (2008) Rafael G. Amado et al. JOURNAL OF CLINICAL ONCOLOGY
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation